These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 35442721)

  • 41. AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
    Couch FJ; Sinilnikova O; Vierkant RA; Pankratz VS; Fredericksen ZS; Stoppa-Lyonnet D; Coupier I; Hughes D; Hardouin A; Berthet P; Peock S; Cook M; Baynes C; Hodgson S; Morrison PJ; Porteous ME; Jakubowska A; Lubinski J; Gronwald J; Spurdle AB; ; Schmutzler R; Versmold B; Engel C; Meindl A; Sutter C; Horst J; Schaefer D; Offit K; Kirchhoff T; Andrulis IL; Ilyushik E; Glendon G; Devilee P; Vreeswijk MP; Vasen HF; Borg A; Backenhorn K; Struewing JP; Greene MH; Neuhausen SL; Rebbeck TR; Nathanson K; Domchek S; Wagner T; Garber JE; Szabo C; Zikan M; Foretova L; Olson JE; Sellers TA; Lindor N; Nevanlinna H; Tommiska J; Aittomaki K; Hamann U; Rashid MU; Torres D; Simard J; Durocher F; Guenard F; Lynch HT; Isaacs C; Weitzel J; Olopade OI; Narod S; Daly MB; Godwin AK; Tomlinson G; Easton DF; Chenevix-Trench G; Antoniou AC;
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1416-21. PubMed ID: 17627006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aldehyde dehydrogenase 2 (ALDH2) polymorphism gene and coronary artery disease risk: a meta-analysis.
    Zhang LL; Wang YQ; Fu B; Zhao SL; Kui Y
    Genet Mol Res; 2015 Dec; 14(4):18503-14. PubMed ID: 26782498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability.
    Healey CS; Dunning AM; Teare MD; Chase D; Parker L; Burn J; Chang-Claude J; Mannermaa A; Kataja V; Huntsman DG; Pharoah PD; Luben RN; Easton DF; Ponder BA
    Nat Genet; 2000 Nov; 26(3):362-4. PubMed ID: 11062481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.
    Moorman PG; Iversen ES; Marcom PK; Marks JR; Wang F; ; Lee E; Ursin G; Rebbeck TR; Domchek SM; Arun B; Susswein L; Isaacs C; Garber JE; Visvanathan K; Griffin CA; Sutphen R; Brzosowicz J; Gruber S; Finkelstein DM; Schildkraut JM
    Breast Cancer Res Treat; 2010 Nov; 124(2):441-51. PubMed ID: 20309627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk.
    Serrano-Fernández P; Debniak T; Górski B; Bogdanova N; Dörk T; Cybulski C; Huzarski T; Byrski T; Gronwald J; Wokołorczyk D; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2009 Sep; 117(1):161-5. PubMed ID: 19030985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of death receptor 4 variant (683A > C) with ovarian cancer risk in BRCA1 mutation carriers.
    Dick MG; Versmold B; Engel C; Meindl A; Arnold N; Varon-Mateeva R; Sutter C; Niederacher D; Deissler H; Preisler-Adams S; Kast K; Schäfer D; Gadzicki D; Heinritz W; Wappenschmidt B; Schmutzler RK
    Int J Cancer; 2012 Mar; 130(6):1314-8. PubMed ID: 21484799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
    Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
    J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.
    Antoniou AC; Sinilnikova OM; Simard J; Léoné M; Dumont M; Neuhausen SL; Struewing JP; Stoppa-Lyonnet D; Barjhoux L; Hughes DJ; Coupier I; Belotti M; Lasset C; Bonadona V; Bignon YJ; ; Rebbeck TR; Wagner T; Lynch HT; Domchek SM; Nathanson KL; Garber JE; Weitzel J; Narod SA; Tomlinson G; Olopade OI; Godwin A; Isaacs C; Jakubowska A; Lubinski J; Gronwald J; Górski B; Byrski T; Huzarski T; Peock S; Cook M; Baynes C; Murray A; Rogers M; Daly PA; Dorkins H; ; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Niederacher D; Deissler H; ; Spurdle AB; Chen X; Waddell N; Cloonan N; ; Kirchhoff T; Offit K; Friedman E; Kaufmann B; Laitman Y; Galore G; Rennert G; Lejbkowicz F; Raskin L; Andrulis IL; Ilyushik E; Ozcelik H; Devilee P; Vreeswijk MP; Greene MH; Prindiville SA; Osorio A; Benitez J; Zikan M; Szabo CI; Kilpivaara O; Nevanlinna H; Hamann U; Durocher F; Arason A; Couch FJ; Easton DF; Chenevix-Trench G;
    Am J Hum Genet; 2007 Dec; 81(6):1186-200. PubMed ID: 17999359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients.
    Lattimore V; Parsons MT; Spurdle AB; Pearson J; Lehnert K; Sullivan J; Lintott C; Bawden S; Morrin H; Robinson B; Walker L
    Breast Cancer Res Treat; 2021 Feb; 185(3):583-590. PubMed ID: 33113089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA-repair genetic polymorphisms and risk of breast cancer in Cyprus.
    Loizidou MA; Michael T; Neuhausen SL; Newbold RF; Marcou Y; Kakouri E; Daniel M; Papadopoulos P; Malas S; Hadjisavvas A; Kyriacou K
    Breast Cancer Res Treat; 2009 Jun; 115(3):623-7. PubMed ID: 18553220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort.
    Freedman ML; Penney KL; Stram DO; Le Marchand L; Hirschhorn JN; Kolonel LN; Altshuler D; Henderson BE; Haiman CA
    Hum Mol Genet; 2004 Oct; 13(20):2431-41. PubMed ID: 15317758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Spurdle AB; Deans AJ; Duffy D; Goldgar DE; Chen X; Beesley J; ; Easton DF; Antoniou AC; Peock S; Cook M; ; Nathanson KL; Domchek SM; MacArthur GA; Chenevix-Trench G
    Breast Cancer Res Treat; 2009 May; 115(2):307-13. PubMed ID: 18543099
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel and reported pathogenic variants in exon 11 of BRCA2 gene in a cohort of Sri Lankan young breast cancer patients.
    De Silva S; Tennekoon KH; Dissanayake A; De Silva K; Jayasekara L
    Fam Cancer; 2017 Jul; 16(3):329-338. PubMed ID: 28039656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.
    Surowy HM; Sutter C; Mittnacht M; Klaes R; Schaefer D; Evers C; Burgemeister AL; Goehringer C; Dikow N; Heil J; Golatta M; Schott S; Schneeweiss A; Bugert P; Sohn C; Bartram CR; Burwinkel B
    Breast Cancer Res Treat; 2014 Jun; 145(2):451-60. PubMed ID: 24728577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delT.
    Finch A; Metcalfe K; Akbari M; Friedman E; Tung N; Rosen B; Eisen A; Karlan B; Foulkes W; Neuhausen SL; Senter L; McKinnon W; Elser C; Sun P; Narod SA;
    Clin Genet; 2022 Mar; 101(3):317-323. PubMed ID: 34897671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
    Ramus SJ; Kartsonaki C; Gayther SA; Pharoah PD; Sinilnikova OM; Beesley J; Chen X; McGuffog L; Healey S; Couch FJ; Wang X; Fredericksen Z; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Barile M; Viel A; Allavena A; Ottini L; Papi L; Gismondi V; Capra F; Radice P; Greene MH; Mai PL; Andrulis IL; Glendon G; Ozcelik H; ; Thomassen M; Gerdes AM; Kruse TA; Cruger D; Jensen UB; Caligo MA; Olsson H; Kristoffersson U; Lindblom A; Arver B; Karlsson P; Stenmark Askmalm M; Borg A; Neuhausen SL; Ding YC; Nathanson KL; Domchek SM; Jakubowska A; Lubiński J; Huzarski T; Byrski T; Gronwald J; Górski B; Cybulski C; Dębniak T; Osorio A; Durán M; Tejada MI; Benítez J; Hamann U; Rookus MA; Verhoef S; Tilanus-Linthorst MA; Vreeswijk MP; Bodmer D; Ausems MG; van Os TA; Asperen CJ; Blok MJ; Meijers-Heijboer HE; ; ; Peock S; Cook M; Oliver C; Frost D; Dunning AM; Evans DG; Eeles R; Pichert G; Cole T; Hodgson S; Brewer C; Morrison PJ; Porteous M; Kennedy MJ; Rogers MT; Side LE; Donaldson A; Gregory H; Godwin A; Stoppa-Lyonnet D; Moncoutier V; Castera L; Mazoyer S; Barjhoux L; Bonadona V; Leroux D; Faivre L; Lidereau R; Nogues C; Bignon YJ; Prieur F; Collonge-Rame MA; Venat-Bouvet L; Fert-Ferrer S; ; Miron A; Buys SS; Hopper JL; Daly MB; John EM; Terry MB; Goldgar D; ; Hansen Tv; Jønson L; Ejlertsen B; Agnarsson BA; Offit K; Kirchhoff T; Vijai J; Dutra-Clarke AV; Przybylo JA; Montagna M; Casella C; Imyanitov EN; Janavicius R; Blanco I; Lázaro C; Moysich KB; Karlan BY; Gross J; Beattie MS; Schmutzler R; Wappenschmidt B; Meindl A; Ruehl I; Fiebig B; Sutter C; Arnold N; Deissler H; Varon-Mateeva R; Kast K; Niederacher D; Gadzicki D; Caldes T; de la Hoya M; Nevanlinna H; Aittomäki K; Simard J; Soucy P; ; Spurdle AB; Holland H; Chenevix-Trench G; Easton DF; Antoniou AC;
    J Natl Cancer Inst; 2011 Jan; 103(2):105-16. PubMed ID: 21169536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Antoniou AC; Spurdle AB; Sinilnikova OM; Healey S; Pooley KA; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Hofmann W; Sutter C; Niederacher D; Deissler H; Caldes T; Kämpjärvi K; Nevanlinna H; Simard J; Beesley J; Chen X; ; Neuhausen SL; Rebbeck TR; Wagner T; Lynch HT; Isaacs C; Weitzel J; Ganz PA; Daly MB; Tomlinson G; Olopade OI; Blum JL; Couch FJ; Peterlongo P; Manoukian S; Barile M; Radice P; Szabo CI; Pereira LH; Greene MH; Rennert G; Lejbkowicz F; Barnett-Griness O; Andrulis IL; Ozcelik H; ; Gerdes AM; Caligo MA; Laitman Y; Kaufman B; Milgrom R; Friedman E; ; Domchek SM; Nathanson KL; Osorio A; Llort G; Milne RL; Benítez J; Hamann U; Hogervorst FB; Manders P; Ligtenberg MJ; van den Ouweland AM; ; Peock S; Cook M; Platte R; Evans DG; Eeles R; Pichert G; Chu C; Eccles D; Davidson R; Douglas F; ; Godwin AK; Barjhoux L; Mazoyer S; Sobol H; Bourdon V; Eisinger F; Chompret A; Capoulade C; Bressac-de Paillerets B; Lenoir GM; Gauthier-Villars M; Houdayer C; Stoppa-Lyonnet D; ; Chenevix-Trench G; Easton DF;
    Am J Hum Genet; 2008 Apr; 82(4):937-48. PubMed ID: 18355772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of association of BRCA1 and BRCA2 variants with breast cancer in an ethnic population of Saudi Arabia, an emerging high-risk area.
    Hasan TN; Shafi G; Syed NA; Alsaif MA; Alsaif AA; Alshatwi AA
    Asian Pac J Cancer Prev; 2013; 14(10):5671-4. PubMed ID: 24289560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ALDH2 Polymorphism and Ethanol Consumption: A Genetic-Environmental Interaction in Carcinogenesis.
    Yang M; Zhang Y; Ren J
    Adv Exp Med Biol; 2019; 1193():229-236. PubMed ID: 31368108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.